Galmed Pharmaceuticals Ltd (NASDAQ:GLMD)

10.03
Delayed Data
As of Mar 27
 -0.28 / -2.72%
Today’s Change
4.58
Today|||52-Week Range
13.50
+72.93%
Year-to-Date
No recent news for Galmed Pharmaceuticals Ltd.

Today’s Trading

Previous close10.31
Today’s open10.44
Day’s range9.90 - 10.84
Volume36,858
Average volume (3 months)68,650
Market cap$111.3M
Dividend yield--
Data as of 4:00pm ET, 03/27/2015

Growth & Valuation

Earnings growth (last year)+447.62%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book3.09

Competitors

 Today’s
change
Today’s
% change
STDYSteadymed Ltd+0.25+3.00%
BLRXBioLine RX Ltd-0.06-2.71%
ZSANZosano Pharma Corp-0.11-1.21%
CPIXCumberland Pharmaceu...-0.10-1.44%
Data as of 4:00pm ET, 03/27/2015

Financials

Last reporting dateMarch 23, 2015
EPS forecast (this quarter)-$0.36
Annual revenue (last year)$0.00
Annual profit (last year)-$17.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
Allen Baharaff
Chief Financial Officer
Josh Blacher
Corporate headquarters
Tel Aviv, Tel Aviv

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account